How the USDA Fast-Tracked Monsanto GMO Seed Approvals

Feb 27, 2012 | Globalist Corporations, News

USDA fast-tracks Monsanto GMO seed approval process

USDA Announces Accelerated GMO Approval Process

In a move that raised serious questions about food safety oversight, the USDA announced plans to dramatically speed up the regulatory review process for genetically modified seeds produced by companies like Monsanto. Despite documented concerns linking GMO crops to organ damage in laboratory studies and the emergence of pesticide-resistant insects, federal regulators stated their intention to cut approval timelines in half.

The revised regulations were expected to take full effect upon publication in the Federal Register. According to USDA deputy administrator Michael Gregoire, the existing process had become too slow due to growing public interest, legal challenges from farmers, and the complexity introduced by national organic food standards.

Corporate Profit Over Public Health Concerns

The USDA framed these obstacles not as legitimate safety concerns but as bureaucratic delays standing in the way of getting new GMO products to market. The underlying pressure appeared to come from the biotech industry itself, which argued that lengthy American approval processes put domestic companies at a competitive disadvantage against countries like Brazil, where GMO seeds moved through regulation with minimal scrutiny.

Steve Censky, then chief executive officer of the American Soybean Association, acknowledged that competition was the driving force behind the push. Financial analyst Jeff Windau put it even more directly, noting that reducing approval time simply meant getting to sales faster.

Regulatory Capture and the Erosion of Oversight

The policy shift illustrated a troubling pattern in which the agency tasked with protecting American agriculture and consumers appeared to prioritize corporate revenue timelines over thorough safety evaluation. By framing public opposition and legal challenges as mere obstacles to efficiency, the USDA effectively signaled that the economic interests of biotech corporations carried more weight than independent scientific review or the concerns of ordinary citizens and farmers.

The episode remains a significant case study in how regulatory agencies can drift from their stated mission when industry pressure becomes the dominant voice in policy decisions.

Related Posts

Power Grid Down Drill To Be Conducted By US Government

Power grid vulnerabilities are finally garnering some attention by government officials. An electrical grid joint drill simulation is being planned in the United States, Canada and Mexico. Thousands of utility workers, FBI agents, anti-terrorism experts, governmental...

read more